CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht

Clin Mol Hepatol. 2019;25(1):42-51. Published online 2018 November 19 DOI: https://doi.org/10.3350/cmh.2018.0029

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Clinical and Molecular Hepatology. 2019;25(1):42-51

Link1

Link2 Link3

P1-096: Eradication of chronic hepatitis C infection with direct acting antivirals is associated with reduction in fibrosis by Transient Elastography (FibroScan)

Journal of Viral Hepatitis. 2018;25:73-73

Link1 Link2

Safety, Tolerability, and Associated Side Effects of Direct- Acting Antivirals

Sidra Rehman

Hepatitis C - From Infection to Cure. 2018;

Link1

How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals

Lawrence Serfaty

Liver International. 2014;35:18-20

Link1 Link2 Link3

New direct-acting antivirals' combination for the treatment of chronic hepatitis C

Tarik Asselah, Patrick Marcellin

Liver International. 2011;31:68-77

Link1 Link2

P1-079: Liver fibrosis regression after HCV treatment with direct acting antivirals in a community-based population

Journal of Viral Hepatitis. 2018;25:63-63

Link1 Link2

Direct-Acting-Antivirals Anti-hepatitis C Virus in Renal Transplant Patients: Relevance of Pharmacologic Interaction

Maurizio Salvadori, Aris Tsalouchos

Journal of Renal and Hepatic Disorders. 2020;4(2):29-33

Link1 Link2 Link3 Link4

Effect of HCV Core Antigen and RNA Clearance during Therapy with Direct Acting Antivirals on Hepatic Stiffness Measured with Shear Wave Elastography in Patients with Chronic Viral Hepatitis C

Mariusz Łucejko, Robert Flisiak

Applied Sciences. 2018;8(2):198

Link1

Sa1533 REGRESSION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS). A LONG-TERM OBSERVATIONAL STUDY.

Christos Triantos, Stavros Kanaloupitis, Konstantinos A. Zisimopoulos, Ioanna Aggeletopoulou, Maria Kalafateli, Georgia Diamantopoulou, Aggeliki Tsintoni, Konstantinos Thomopoulos

Gastroenterology. 2020;158(6):S-1323

Link1 Link2

Noninvasive diagnosis of fibrosis in the patients with hepatitis C virus infection treated with direct-acting antivirals

H. Numao, K. Shimaya, K. Hasui, K. Igarashi

Journal of Hepatology. 2018;68:S547

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.